Corporate News Archives | Page 5 of 10

George Clinical’s Parent Company The George Institute For Global Health Secures Largest Ever NHMRC Project Grant To Benefit People With Kidney Disease

George Clinical congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) globally and benefit millions of people globally. The $5.5 million awarded by the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research, is […]

February 5th, 2019

George Clinical Scientific Leader research contributions recognized with leading Lancet profile.

George Clinical welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke research”. “It is our engagement with scientific leaders, such as Professor Anderson, that sets George Clinical apart from other CROs,” said Philip Gregory, Managing Director, China. “The Lancet […]

January 29th, 2019

George Clinical Welcomes WCC Partnership with OneOncology

George Clinical welcomes the recent announcement by our partner organization, West Cancer Center of their intention to join OneOncology in January 2019. The announcement sees a departure from their existing relationship with Methodist Le Bonheur Healthcare, an affiliation they have held since 2011. The affiliation with OneOncology will place West Cancer Center as a nationally […]

January 29th, 2019

George Clinical announces the appointment of James Cheong to the role of Chief Operating Officer

SYDNEY, January 22, 2019 – George Clinical, headquartered in Sydney, Australia, a global scientifically backed CRO, today announced the appointment of James Cheong to the role of Chief Operating Officer. With extensive management experience spanning over two decades, Cheong brings valuable leadership to George Clinical’s executive team during a period of strong expansion and growth. […]

January 22nd, 2019

George Clinical Recognized with Employer Award by Hong Kong Authority

George Clinical, a leading clinical research organization (CRO) in the Asia-Pacific region, has gained recognition of the organization’s strong support of the Mandatory Provident Fund (MPF) legislation, and their provision of good MPF benefits. The Mandatory Provident Fund Schemes Authority (MPFA) awarded George Clinical their Good MPF Employer Award at a ceremony in Hong Kong […]

January 5th, 2019

There has never been a better time to consider China as part of your development strategy!

In another encouraging step towards making China a leading destination for clinical drug trials, some critical developments were announced at The Executive Meeting of the State Council on the 12th April 2018. From 1 May 2018, the import tariff of all common drugs including anticancer drugs, alkaloids with anticancer effects and the imported Chinese patent […]

April 19th, 2018

Utilizing clinical research organization for late phase I studies

George Clinical Promotes Matthew Reabold, Sr., to Head of Business Development, USA

George Clinical, a leading full-service CRO in the US and Asia-Pacific region, is pleased to announce that Matthew Reabold, Sr. has been promoted to the Head of Business Development, USA. George Clinical, headquartered in Sydney, Australia, operates in fifteen countries around the world and has major operational hubs in the USA, East Asia, China, and India. Matthew, who is USA based, will […]

December 13th, 2017

George Clinical, leading Asia-Pacific CRO, expands into US with acquisition of a specialised oncology CRO Division

Sydney, Australia (May 2, 2017) – George Clinical, a leading full-service CRO in the Asia-Pacific region and Vector Oncology, a Memphis-based leader in oncology research and data analytics, formally announced today that George Clinical has acquired Vector Oncology’s CRO Division. Effective immediately, the transaction has the dual purpose of strengthening the ability of George Clinical […]

May 3rd, 2017

Hong Kong Wholesale Dealer Licence

George Clinical is pleased to announce the receipt of their Hong Kong Wholesale Dealer licence issued by the Department of Health on the 3rd April. This licence represents a significant step forward in George Clinical’s operations in Hong Kong, allowing them to apply for a Certificate of Clinical Trial on behalf of the sponsor and […]

May 2nd, 2017

George Clinical welcomes Kristina Figueroa and Mindy Farr to the George Clinical team

George Clinical is pleased to announce the continued expansion of their Business Development operations in the US, with the recent appointments of Mindy Farr as Senior Business Development Manager and Kristina Figueroa, Business Development Manager. “Both Mindy and Kristina are joining George Clinical at an exciting time in the organisation’s history”, Mr Clark said. “We […]

February 3rd, 2017

Corporate News

Sign Up For Our Newsletter